|
UCB and Baylor College of Medicine launch strategic alliance in neurodegeneration
|
12 February 2016 |
|
UCB to focus on core business in India
|
02 April 2015 |
|
UCB and Biogen Idec enter agreement to commercialize multiple sclerosis and hemophilia therapies in Asia
|
30 January 2014 |
|
Multimillion pound investment in UK life sciences research and development
|
11 December 2013 |
|
Cimzia® (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis
|
30 September 2013 |
|
UCB announces regulatory filings for Cimzia® (certolizumab pegol)
|
20 February 2013 |
|
Accelerating focus on the patient
|
14 February 2013 |
|
UCB announces third research collaboration with Harvard University
|
10 October 2012 |
|
UCB half year results 2012: on track for growth
|
01 August 2012 |
|
UCB expands in Brazil
|
30 May 2012 |
|
UCB marks World Parkinson's Disease Day with new Parkinson's Well-Being Map™
|
11 April 2012 |
|
Neupro® approved by U.S. FDA for Parkinson's disease and Restless Legs Syndrome
|
03 April 2012 |
|
Positive top-line result for UCB's Cimzia® in psoriatic arthritis
|
16 February 2012 |